Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy.
- DOI
- 10.1016/j.jfma.2026.04.013
- Published
- 2026 Apr 6
- Container
- Journal of the Formosan Medical Association = Taiwan yi zhi
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jfma.2026.04.013,
title = {Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy.},
author = {Wu JY and Zhuo J and Chen YC and Wang SP and Hsieh JF and Shih JY},
year = {2026},
journal = {Journal of the Formosan Medical Association = Taiwan yi zhi},
doi = {10.1016/j.jfma.2026.04.013},
url = {https://doi.org/10.1016/j.jfma.2026.04.013}
}RIS
TY - JOUR TI - Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy. AU - Wu JY AU - Zhuo J AU - Chen YC AU - Wang SP AU - Hsieh JF AU - Shih JY PY - 2026 JO - Journal of the Formosan Medical Association = Taiwan yi zhi DO - 10.1016/j.jfma.2026.04.013 UR - https://doi.org/10.1016/j.jfma.2026.04.013 ER -
APA
JY, W., J, Z., YC, C., SP, W., JF, H., & JY, S. (2026). Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy.. Journal of the Formosan Medical Association = Taiwan yi zhi. https://doi.org/10.1016/j.jfma.2026.04.013
Source records
- pubmed · retrieved 2026-09-26T04:15:09.657Z